Tel Aviv University reveals brain cancer cure breakthrough – The Jerusalem Post

Tel Aviv University scientists made a groundbreaking discovery in the fight against brain cancer by avoiding glioblastoma from spreading, according to a press release.Glioblastoma is an aggressive type of cancer that can take place in the brain or spine cord.The researchers handled to accomplish the breakthrough by finding a failure in the brains body immune system that can be used versus the deadly cancer. The failure in question stems from a protein called P-Selectin (SELP), which researchers utilized to bring back the regular activity of the brain, obstructing the spread of the cancer.Prof. Ronit Satchi-Fainaro of Tel Aviv Universitys Sackler Faculty of Medicine led the global research group in the venture. Researchers likewise compared healthy brain tissues with other tissues infected with glioblastoma. “We examined the interactions between the immune cells in the glioblastoma and the brain cells in tumors that were just recently eliminated from patients brains,” said Fainaro.Researchers studied which proteins are secreted when the microglia immune cells (the cells of the body immune system) satisfy with the glioblastoma cells, as cells have the ability to interact with one another through proteins. Their studies led to the SELP protein, which was exposed to be disrupting brain body immune system functions and boosting glioblastoma tumors.Fainaro believes that the study might have therapeutic ramifications, as there is the possibility that SELP might be used to treat pain associated with sickle cell anemia. cnxps.cmd.push(function () ); if(window.location.pathname.indexOf(“656089”)!= -1)

Leave a Reply

Your email address will not be published. Required fields are marked *